最近新增的股票 (30 天)

您沒有最近查詢的記錄。
chg | %

Formosa Laboratories, Inc.  

(�W�����q TPE:4746)   �l�ܦ��Ѳ�  
�j�M��h4746���������G
70.40
0.00 (0.00%)
11��20�� - ����
TPE ���Y�ɸ�� - �K�d�n��
�d�� 70.20 - 71.10
52 �g 69.50 - 102.00
�}���� 70.90
����q 73.90�U
�`���� 65.48��
���ղv 18.61
�Ѯ�/���q 2.88/4.09
�C�ѬէQ 3.78
�ѥ� 9301.30�U
�ॴ�t��     -
���c���Ѳv�G     -

����έp�ƾڻP��v

2017�~ 9�� 2016�~
�b�Q��v 6.22% 15.16%
��~�Q��v 9.16% 20.80%
��税���«e�Q�� - 29.11%
�����겣�^���v 2.25% 7.33%
�����ѥ��^���v 3.95% 12.78%
���u 480 -
CDP Score - -

�a�}

No.36, Hoping Street, Kengkou Village
TAOYUAN, 338
Taiwan
+886-3-3240895 (�q��)
+886-3-3240945 (�ǯu)

�����s��

²��

Formosa Laboratories, Inc. is a Taiwan-based company principally engaged in the development, production and distribution of ultraviolet (UV)-proof active ingredients, bulk pharmaceutical chemicals, antibody drug conjugates, as well as the provision of customized services. The Company primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The Company distributes its products to Europe, the Americas, Asia and other markets.

���Ƨ�

Zhengyu Cheng Chairman of the Board, General Manager
Yuzhen Luo Deputy General Manager-Operations Support and Finance
Jianmin Lin Deputy General Manager-Project and Official Business
Shanzhen Liu Deputy General Manager-Business Division
Qingpeng Wei Deputy General Manager-Research and Development
Shaohong Chen Director
Sifeng Chen Director
Jianhong Li Director
Mingwen Li Director
Lujie Wang Director